AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

And that blow arrived just two days later when global pharmaceutical giants AstraZeneca (AZ) suddenly revealed they were ...

Earnings per share excluding some items surged to $2.09, Astra said Thursday, higher than the $2.04 estimated by analysts ...

AstraZeneca announced that it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, a figure significantly lower than some investors had feared. The ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

Q4 2024 Earnings Call Transcript February 6, 2025 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.05 EPS, ...

As part of his love-in with infrastructure, the Prime Minister is vowing to 'rip up the rules' and grant planning licences ...

How an agreement set up by the Tories and lauded by Labour fell victim to cost-cutting and UK curbs on drugs expenditure ...

THE Bank of England yesterday lowered interest rates from 4.75 per cent to 4.5, while halving its growth forecasts amid fears ...

Find insight on Siemens Healthineers , Eli Lilly, AstraZeneca, and more in the latest Market Talks covering Health Care.

The company has no further information to share about Wang and is not permitted by Chinese authorities to speak to him, Pascal Soriot said at a press conference after the company released ...